(BIAF) bioAffinity Technologies, Inc. Discounted Cash Flow Financial Model

US | Healthcare | Medical - Diagnostics & Research | NASDAQ
(BIAF) bioAffinity Technologies, Inc. Discounted Cash Flow Financial Model

Fully Editable: Tailor To Your Needs In Excel Or Sheets

Professional Design: Trusted, Industry-Standard Templates

Investor-Approved Valuation Models

MAC/PC Compatible, Fully Unlocked

No Expertise Is Needed; Easy To Follow

(BIAF) bioAffinity Technologies, Inc. Complete Analysis Pack

Get Full Bundle:
$19 $9
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5
Icon

A Practical Valuation Tool for Smarter Decisions

This DCF Financial Model helps you estimate intrinsic value using forecast cash flows, discount rates, and valuation assumptions. This page already shows a real preview of the Excel model, so you can review the structure and content before buying. Purchase the full version to get the complete ready-to-use file.

What is included in the product

10-K Data Entered

10-K Data

Historical 10-K financials are included to help analyze past performance before forecasting.

Discounted Cash Flow Model

Discounted Cash Flow Model

A ready-built DCF model helps estimate intrinsic value from projected future cash flows.

Editable Inputs

Editable Inputs

Highlighted input cells let you adjust assumptions and update the valuation instantly.

Financial Statements

Financial Statements

Historical financial statements are organized in one place for faster review and analysis.

Key Ratios

Key Ratios

Key ratios help evaluate profitability, leverage, efficiency, and overall financial health.

Dasboard with Charts

Dashboard with Charts

A visual dashboard with charts shows valuation outputs, assumptions, and trends at a glance.

Icon

What you Will Get

Icon

Income Statement:

Historical figures already included to help review revenue, profitability, and operating performance for bioAffinity Technologies, Inc..

Icon

Balance Sheet:

Structured company data inside for analyzing assets, liabilities, and capital structure over time at bioAffinity Technologies, Inc..

Icon

Cash Flow Statement:

Ready for valuation analysis with historical cash flow data already organized in the model.

Explore a Preview
Icon

Linked Formulas:

Calculations flow automatically across the workbook for faster updates and more consistent analysis.

Icon

Scenario Testing:

Compare different valuation cases by adjusting assumptions and reviewing the impact instantly for bioAffinity Technologies, Inc..

Preview the Actual Deliverable
bioAffinity Technologies, Inc. Discounted Cash FLow Financial Model

This preview shows the actual DCF Financial Model you will receive after purchase, not a mockup or simplified sample. The Excel file is pre-filled with company-specific historical financial data and built for immediate valuation work. What you see here is the same ready-to-use model available for download after payment.

Explore a Preview
Icon

Key Features

Icon

Company Focus:

bioAffinity Technologies, Inc. develops products for early detection and treatment support in healthcare.

Icon

Specialized Approach:

bioAffinity Technologies, Inc. uses targeted scientific methods to address clinical testing needs.

Icon

Healthcare Application:

The company's work is centered on improving diagnostic and therapeutic pathways.

Explore a Preview
Icon

Research Driven:

Scientific development supports the company's product direction and market focus.

Icon

Clear Positioning:

bioAffinity Technologies, Inc. is positioned around healthcare innovation and diagnostic solutions.

Icon

Who Should Use It

Icon

Equity Investors:

Built for investors who want to review bioAffinity Technologies, Inc. before making a stock decision.

Icon

Research Teams:

Useful for teams analyzing bioAffinity Technologies, Inc. with a structured company review format.

Icon

Stock Analysts:

Designed for analysts who need a clear framework to evaluate the company and compare it with peers.

Explore a Preview
Icon

Portfolio Managers:

Helpful for professionals reviewing valuation and risk across public companies.

Icon

Value Investors:

Suitable for buyers focused on comparing market price with modeled fair value.

Icon

Why Choose bioAffinity Technologies, Inc.

Icon

Company Overview:

bioAffinity Technologies, Inc. is presented in a clear format for finance and research use.

Icon

Analyst-Friendly Format:

The content is structured to support analysts, investors, and other finance users.

Icon

Practical Over Theoretical:

You get a working company model instead of a broad textbook-style template.

Explore a Preview
Icon

Useful Across Cases:

The workbook works for research, investing, review, and internal planning needs for bioAffinity Technologies, Inc.

Icon

Efficient Workflow:

The model reduces friction between gathering data, building forecasts, and valuing bioAffinity Technologies, Inc.

Icon

How It Works

Icon

Open and Review:

You open the model and review the company-specific historical financial base for bioAffinity Technologies, Inc..

Icon

Edit Key Drivers:

You update the few assumptions that have the biggest effect on value for bioAffinity Technologies, Inc..

Icon

Refresh the Forecast:

The model automatically rebuilds projected statements after each assumption change.

Explore a Preview
Icon

Check Sensitivities:

You can see how valuation changes when assumptions move up or down.

Icon

Use the Dashboard:

Charts and summaries help you review the full valuation picture faster.


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.